The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCAT 2024 | Moving basic science research from bed to bench and bench to bed
In this video, Sara El Hoss, PhD, Imagine Institute of Genetic Diseases, Paris, France, provides insight into her talk titled ‘What is basic science research – from bed to bench and bench to bed.’ Dr El Hoss highlights the importance of both translating basic science research into clinical care and using novel insights from the clinic to inform further investigations in the laboratory. This interview took place at the 19th Annual Scientific Conference of the Academy for Sickle Cell and Thalassaemia (ASCAT 2024) in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
So this year I was given the task to speak about the importance of basic science research and how the research that we do in the lab can be translated to helping the patients in the hospitals. And in my talk what I want to cover is the idea of really moving the research from the bench directly to the bed of the patients and also moving what we see in the clinic, new symptoms or any complications that we observe in the clinic, how to use them to help us understand what’s happening in the lab and how we can dissect these these complications to understand the pathophysiology of the disease so then we can maybe provide novel therapies to patients...
So this year I was given the task to speak about the importance of basic science research and how the research that we do in the lab can be translated to helping the patients in the hospitals. And in my talk what I want to cover is the idea of really moving the research from the bench directly to the bed of the patients and also moving what we see in the clinic, new symptoms or any complications that we observe in the clinic, how to use them to help us understand what’s happening in the lab and how we can dissect these these complications to understand the pathophysiology of the disease so then we can maybe provide novel therapies to patients.
Read more...
